Non Small CellInfo Center
FDA OKs Targeted Lung Cancer Rx
The US Food and Drug Administration (FDA) has approved a targeted drug for a type of non-small cell lung cancer.
A Drop in Lung Cancer Deaths
Deaths from the most common type of lung cancer have decreased rapidly in recent years. Researchers are saying new treatments are behind this good news.
FDA Approved Treatment Option - Non Small Cell Lung Cancer
An Approved Treatment Option For Previously Treated Advanced NSCLC. Learn More.
Lung Cancer Rx Receives FDA Approval
A lung cancer drug has received regular approval from the US Food and Drug Administration (FDA).
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
A New Job for Xalkori
The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.
Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.
FDA Approves Rx for Combo Treatment of Lung Cancer
The US Food and Drug Administration (FDA) has approved a new medication for the treatment of non-small cell lung cancer (NSCLC).
Single Gene Doubled Risk of Lung Cancer
After decades of public health initiatives, it’s no secret that smoking is bad for your health and can ultimately cause lung cancer.